Renjing Biology
Suzhou · Founded 2021
About Renjing Biology
Renjing Biotechnology is a biopharmaceutical company. It also engages in the development of therapeutic tumor vaccines, tumor immunotherapy drugs, and protein substitutes, providing customers with advanced therapeutic solutions.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $14.4M
- Funding stage: Seed
- Last round: Seed (Feb 2023)
- Website: rinuagene.com
- Phone: +86 0512 6288 9805
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/renjing-biology-96312 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.